Shree Hari Intl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHREE HARI INTL, and what generic and branded alternatives to SHREE HARI INTL drugs are available?
SHREE HARI INTL has three approved drugs.
Drugs and US Patents for Shree Hari Intl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shree Hari Intl | ETODOLAC | etodolac | TABLET;ORAL | 074839-001 | Jul 11, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Shree Hari Intl | ETODOLAC | etodolac | TABLET;ORAL | 074846-001 | Feb 28, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Shree Hari Intl | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | LOTION;TOPICAL | 070274-001 | Aug 12, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.